Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

Université de Montréal

$105,539.00

Biosynthetic alternatives to human donor corneal transplantation

FY 2017-18

Summary
The cornea is the outer window to the eye that transmits light to the retina for vision.Permanent transparency loss, due to disease or damage, can result in vision loss andblindness. Transplantation of human donor corneas is the only widely accepted treatment, butit is overshadowed by a worldwide shortage (only 1 donor cornea available for every 70needed) and functional limitations (sub-optimal optical results, rejection, and graft failure),particularly in very sick eyes with inflammation and infection.Our goals are (1) to overcome the donor shortage and to improve surgical outcomes bydeveloping biosynthetic alternatives to donor corneas, and (2) to revolutionize cornea surgicalmethods so that patients can be treated by removing only the damaged tissue and filling theresulting tissue gap with a transparent, injectable hydrogel that will be polymerized in situinstead of a full transplantation, somewhat like dental fillings.In regenerative medicine, biomaterials are used as scaffolds to promote tissue repair. Ourapproach consists in designing collagen mimics at the nanoscale level and allowing these toself-assemble into full size 3-D scaffolds after injection into the diseased cornea. We will thenuse light to start the crosslinking reaction, to form a stable, transparent graft.Our proposed new treatment comprising of a new surgical paradigm and new biomaterials willoffer a minimally invasive and unequaled alternative for sight restoration. Our approach willhave a tremendous impact in patients who currently have very poor prognosis with traditionalcorneal transplantation.
Program
Collaborative Health Research Projects
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
508338-2017
Name nom
Brunette, Isabelle
Department département
Ophtalmologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
105539
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
3
Application title
Biosynthetic alternatives to human donor corneal transplantation
Keyword
NSERC
Application summary
The cornea is the outer window to the eye that transmits light to the retina for vision.Permanent transparency loss, due to disease or damage, can result in vision loss andblindness. Transplantation of human donor corneas is the only widely accepted treatment, butit is overshadowed by a worldwide shortage (only 1 donor cornea available for every 70needed) and functional limitations (sub-optimal optical results, rejection, and graft failure),particularly in very sick eyes with inflammation and infection.Our goals are (1) to overcome the donor shortage and to improve surgical outcomes bydeveloping biosynthetic alternatives to donor corneas, and (2) to revolutionize cornea surgicalmethods so that patients can be treated by removing only the damaged tissue and filling theresulting tissue gap with a transparent, injectable hydrogel that will be polymerized in situinstead of a full transplantation, somewhat like dental fillings.In regenerative medicine, biomaterials are used as scaffolds to promote tissue repair. Ourapproach consists in designing collagen mimics at the nanoscale level and allowing these toself-assemble into full size 3-D scaffolds after injection into the diseased cornea. We will thenuse light to start the crosslinking reaction, to form a stable, transparent graft.Our proposed new treatment comprising of a new surgical paradigm and new biomaterials willoffer a minimally invasive and unequaled alternative for sight restoration. Our approach willhave a tremendous impact in patients who currently have very poor prognosis with traditionalcorneal transplantation.
Université de Montréal - $105,539 Grant (2017-18) | Canada Spends